RFP
TECX

Root Financial Partners’s Tectonic Therapeutic TECX Stock Holding History

Root Financial Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$155 – 3329
2026
Q1 		$155 Buy
+5
New +$123 ﹤0.01% 3204

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Root Financial Partners's TECX Position: Q2 2026 in Review

Root Financial Partners sold out of Tectonic Therapeutic (TECX) in Q2 2026, closing a stake of 5 shares — an estimated $155 sold.

Root Financial Partners first reported a position in TECX in Q1 2026 and held it in 1 quarter. The position peaked at $155 in Q1 2026. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Root Financial Partners reported no remaining Tectonic Therapeutic position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 5 Tectonic Therapeutic shares in Q2 2026, an estimated $155.
  • Root Financial Partners first reported a position in Tectonic Therapeutic in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Tectonic Therapeutic position peaked at $155 in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.